skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Appendix B: Acronyms

(Last updated: March 1, 2016; last reviewed: March 1, 2016)

Appendix B: Acronyms
Acronym/Abbreviation
Full Name
3TC lamivudine
ABC
abacavir
AE adverse effect
ALP
alkaline phosphatase
ALT
alanine aminotransferase
ANC
absolute neutrophil count
ART
antiretroviral therapy
ARV
antiretroviral
AST
aspartate aminotransferase
ATV
atazanavir
ATV/r
ritonavir-boosted atazanavir
AUC
area under the curve
AV
atrioventricular
BMD
bone mineral density
BMI
body mass index
BSA body surface area
CBC
complete blood count
CDC
Centers for Disease Control and Prevention
CI confidence interval 
CK
creatine kinase
Cmax
maximum plasma concentration
Cmin
minimum plasma concentration
CMV
cytomegalovirus
CNS
central nervous system
COBI
cobicistat
CrCl
creatinine clearance
CT
computed tomography
CVD
cardiovascular disease
CYP
cytochrome P
d4T
stavudine
ddI
didanosine
DM
diabetes mellitus
DMPA
depot medroxyprogesterone acetate
DOT
directly observed therapy
DRESS
drug rash with eosinophilia and systemic symptoms
DRV
darunavir
DRV/r
ritonavir-boosted darunavir
DXA
dual-energy x-ray absorptiometry
EBV
Epstein-Barr virus
EC
enteric-coated
ECG
electrocardiogram
EFV
efavirenz
EM
erythema multiforme
ETR etravirine
EVG elvitegravir
FDA
Food and Drug Administration
FLP fasting lipid profile
FPG
fasting plasma glucose
FPV
fosamprenavir
FPV/r
ritonavir-boosted fosamprenavir
FTC
emtricitabine
FXB
François-Xavier Bagnoud Center
G6PD
glucose-6-phosphate dehydrogenase
G-CSF
granulocyte colony-stimulating factor
GFR
glomerular filtration rate
GI
gastrointestinal
HAV
hepatitis A virus
HBV
hepatitis B virus
HCV
hepatitis C virus
HDL
high-density lipoprotein
HDL-C
high-density lipoprotein cholesterol
Hgb
hemoglobin
HHS
U.S. Department of Health and Human Services
HIVMA
HIV Medicine Association
HRSA
Health Resources and Services Administration
HSR
hypersensitivity reaction
HSV
herpes simplex virus
IAS-USA
International Antiviral Society-USA
ICH
intracranial hemorrhage
IDSA
Infectious Diseases Society of America
IDV
indinavir
IMPAACT International Maternal Pediatric Adolescent AIDS Clinical Trials Network
INH isoniazid
INSTI
integrase strand transfer inhibitor
IQ
inhibitory quotient
IRIS
immune reconstitution inflammatory syndrome
IU
international units
IV
intravenous/intravenously
IVIG
intravenous immune globulin
LDL
low-density lipoprotein
LDL-C
low-density lipoprotein cholesterol
LFT
liver function test
LLQ
lower level of quantification
LPV
lopinavir
LPV/r
ritonavir-boosted lopinavir
MEMS
Medication Event Monitoring System
MVC
maraviroc
NASBA nucleic acid sequence-based amplification
NAT nucleic acid test 
NFV
nelfinavir
NHLBI National Heart, Lung, and Blood Institute 
NIH
National Institutes of Health
NNRTI
non-nucleoside reverse transcriptase inhibitor/non-nucleoside analogue reverse transcriptase inhibitor
non-HDL-C
non-high-density lipoprotein cholesterol
NRTI
nucleoside reverse transcriptase inhibitor/nucleoside analogue reverse transcriptase inhibitor
NVP
nevirapine
OARAC
Office of AIDS Research Advisory Council
OGTT
oral glucose tolerance test
OI
opportunistic infection
PCP
Pneumocystis jiroveci pneumonia
PCR
polymerase chain reaction
PG
plasma glucose
Pgp
p-glycoprotein
PI
protease inhibitor
PK
pharmacokinetic
PPI
proton-pump inhibitor
PR
protease
PUFA
polyunsaturated fatty acid
py patient years 
RAL
raltegravir
RBV
ribavirin
RPG
random plasma glucose
RPV
rilpivirine
RT
reverse transcriptase
RTV
ritonavir
SJS
Stevens-Johnson syndrome
SMR sexual maturity rating 
SQ
subcutaneous
SQV
saquinavir
T-20
enfuvirtide
TAF tenofovir alafenamide 
TB
tuberculosis
TC
total cholesterol
TDF
tenofovir disoproxil fumarate
TDM
therapeutic drug monitoring
TEN
toxic epidermal necrolysis
TG
triglyceride
THAM
tris–hydroxymethyl-aminomethane
TMP-SMX
trimethoprim sulfamethoxazole
TPV
tipranavir
TPV/r
ritonavir-boosted tipranavir
UGT
uridine diphosphate glucoronosyltransferase
ULN
upper limit of normal
USPHS
U.S. Public Health Service
WHO
World Health Organization
ZDV
zidovudine

Back to Top